Completed PHASE2 INTERVENTIONAL NCT00000301

Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4

Rapid Evaluation of Cocaine Pharmacotherapies (Amantadine)

Sponsor: National Institute on Drug Abuse (NIDA)

Interventions Amantadine

Updated 5 times since 2017 Last updated: Jul 7, 2016 Started: Mar 31, 1996 Primary completion: Jun 30, 1998

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cocaine-Related Disorders, this trial is completed. The trial is conducted by National Institute on Drug Abuse (NIDA) and has accumulated 5 data snapshots since 1996. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 1996

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
University of California, Los Angeles

Data source: University of California, Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States